This finding suggest that the key cytokines TGF-β1 and IL-6 work together with IL-17 during acute anti-thy1 glomerulonephritis and a potential therapy may aim at a concerted inhibition of these cytokines. The gene discussed is THY1; the disease is glomerulonephritis.